Matrix Science Medica (MSM)

HORMONAL IMBALANCE AND MOOD DISORDERS ACROSS DIFFERENT AGE GROUPS

Author archives:

msm.01.2026.32.36

ABSTRACT

HORMONAL IMBALANCE AND MOOD DISORDERS ACROSS DIFFERENT AGE
GROUPS

Matrix Science Medica (MSM)
Author: Phone Myint Htoo, Wana Hla Shweb, Jason Lim Yang Jiens, Nurin Sofia Azman, , Nur Elijah Suada Rusli, Khooi Zhong Yid, Chan Foo Khin and Nazmul MHM, Srikumar Chakravarthi

DOI: 10.4103/MTSM.MTSM_32_36

Hormonal imbalance is an important biological factor that can affect emotional regulation, psychological stability, and mood disorder burden across different stages of life. Because endocrine changes occur during adolescence, reproductive age, postpartum, midlife, and later adulthood, their influence on mood may vary by age and hormonal pathway. Existing literature has shown strong links between thyroid dysfunction, reproductive hormone imbalance, postpartum endocrine change, and mood-related outcomes such as depression, anxiety, irritability, and emotional instability. However, much of the current research has focused on specific hormonal conditions or isolated life stages, which has limited a broader understanding of how hormonal imbalance affects mood disorders across age groups in an integrated way. This study was therefore conducted to provide a more age-sensitive understanding of the problem. The article examines major hormonal imbalance categories, compares their emotional effects across life stages, and discusses how endocrine disruption contributes to mood disorder burden in different age groups. Overall, the study concludes that hormonal imbalance has a clear but age-dependent influence on mood disorders, and that age-based endocrine interpretation is important for stronger clinical understanding.
Pages 32-36
Year 2026
Issue 1
Volume 10

Download

Posted by aiman

msm.01.2026.37.40

ABSTRACT

INFERTILITY CONCEPTS IN ANCIENT MESOPOTAMIA

Matrix Science Medica (MSM)
Author: Bayar A Qasim, Hasan A Qasim, Ayad A Mohammed, Ameen M Mohammad, Halder J Abozait

DOI: 10.4103/MTSM.MTSM_37_40

Fertility was a major concern for human beings at early stages of existence. The fundamental reason for this was both an increase in the race and the survival of the nation. According to their entrenched belief that all successful steps necessitate the God’s blessing, fertility, similarly, was seen as a sign of blessing. In some other Mesopotamian and Mediterranean regions, the fertility goddess was represented by such symbols as the genital organs of the woman, such as rhombs, the obvious genital shapes, and pubic triangle. The data collection was based on archeological works carried out by teams from the Directorate of Antiquities in Duhok, a city in Iraq’s Kurdistan Region in 2019. The discovery of numerous mother goddesses refers to the important role that God’s blessing in fertility plays in the life of the people settled in this region until today. This belief is also present in Kurdistan Region of Iraq. In ancient Kurdistan region of Iraq, we observed a number of fertility goddesses and the God of desire, which reflects the importance of reproduction concept among those nations, who lived in this region.
Pages 37-40
Year 2026
Issue 1
Volume 10

Download

Posted by aiman

msm.01.2026.28.31

ABSTRACT

BIOMARKERS AND BEHAVIORAL INDICATORS ASSOCIATED WITH EARLY-STAGE DEPRESSION DIAGNOSIS

Matrix Science Medica (MSM)
Author: Manglesh Waran Udayah, Deepthi Shridhar Puttur, Sandra Rumi Madhus, Vincent Leong CS4, Gaayatree Rao Ne, Arvinderan Balakumarans, Aishvini Kumakhan, Darian Yeap JJ, Chan Foo Khins, Prithivan Ravichandran and Nazmul MHM

DOI: 10.4103/MTSM.MTSM_28_31

Depression is a major mental health challenge, and its early-stage diagnosis is difficult because initial symptoms are often mild, mixed, and not clearly visible. This creates a need for screening methods that can detect early depressive change through more objective indicators. Existing studies have shown that biomarkers such as neural and inflammatory signals, along with behavioral indicators such as speech, facial response, and expressive change, can support depression detection. However, earlier work has examined these signals separately, which limits the ability to capture the full pattern of early-stage depression. This research was therefore needed to address the gap between single-domain models and the clinical need for a more integrated screening framework. In this article, a multimodal methodology is presented that combines biomarker screening, behavioral indicator extraction, feature integration, and early-stage depression classification within one structured framework. The results showed that the integrated model performed better than biomarker-only and behavior-only models, indicating that early depression is better recognized when biological evidence and behavioral signals are examined together. Overall, the study concludes that multimodal screening provides a more complete and clinically useful direction for the early diagnosis of depression.
Pages 28-31
Year 2026
Issue 1
Volume 10

Download

Posted by aiman

msm.01.2026.23.27

ABSTRACT

UPDATE ON MANAGEMENT OF BELL’S PALSY: A SCOPING REVIEW

Matrix Science Medica (MSM)
Author: Santosh Kumar Swain

DOI: 10.4103/MTSM.MTSM_23_27

Bell’s palsy is the most frequent cause of unilateral peripheral facial nerve palsy with an acute onset. Although the exact cause of Bell’s palsy is unknown, there is evidence that it is likely related to viral infections such herpes zoster virus and herpes simplex virus-1 (HSV-1). Bell’s palsy symptoms usually peak in the first week and then progressively go away over the course of three weeks to three months. It often occurs in patients with diabetes mellitus and in pregnant women. Diagnosis of Bell’s palsy is purely on clinical basis. Management of Bell’s palsy aims to achieve complete recovery and reduce negative sequelae of patients that do not resolve spontaneously. Treatment should be started early in the course of the disease and within 72 hours of onset. Both antiviral and corticosteroids are used as treatment strategies. Patients who get corticosteroids alone had better results than those who just receive antivirals, Additionally, antiviral medications are no more effective than a placebo.

Pages 23-27
Year 2026
Issue 1
Volume 10

Download

Posted by aiman

msm.01.2026.19.22

ABSTRACT

NUTRITIONAL DEFICIENCIES AND THEIR IMPACT ON MOOD AND COGNITIVE FUNCTION

Matrix Science Medica (MSM)
Author: Priyanka C, Siti Safura Jaapar, Mahabuba Afrin, Negar Shafiei Sabets, Saeid Reza Doustjalalis, Harsimran Kaur Dhanoa, Alvin Yee WW, Nur Elijah Suada Rusli, Sutha Devaraj and Nazmul MHM**

DOI: 10.4103/MTSM.MTSM_19_22

Nutritional deficiencies are increasingly recognized as important contributors to both mood disturbance and cognitive decline. Because the brain depends on adequate vitamins, minerals, and essential fatty acids for neurotransmission, energy metabolism, and neuronal stability, poor nutritional status may weaken both emotional and cognitive health. Existing literature has linked deficiencies in vitamin D, vitamin B12, omega-3 fatty acids, iron, folate, and related micronutrients with depression, anxiety, fatigue, memory weakness, and reduced cognitive clarity. However, much of this research has examined mood and cognition separately or has focused on single nutrients, which limits an integrated understanding of their combined effects. Synthesizing evidence in a clinically relevant and interconnected way was the primary objective of this study. The article examines the primary nutritional deficiencies and their mood-related and cognitive outcomes and describes the remaining evidence. The article shows how these deficiencies may overlap and suggests multiple emotional and mental processes may be most adversely impacted by deficiencies of vitamin D, vitamin B12, and omega-3. This article stresses the importance of assessing nutrition when evaluating mental and cognitive health.

Pages 19-22
Year 2026
Issue 1
Volume 10

Download

Posted by aiman

msm.01.2026.10.18

ABSTRACT

SECONDARY METABOLITES IN SENNA OBTUSIFOLIA AS POTENTIAL DRUG CANDIDATE FOR TREATMENT OF AFLATOXIN SYNTHESIS

Matrix Science Medica (MSM)
Author: Zacchaeus S. Ololade, Oluwafemi A. Ojord, Richard A. Oyero, Olayinka F. Onifade and Olawumi T. Oyebanji/span>

DOI: 10.4103/MTSM.MTSM_10_18

Senna obtusifolia is a medicinal plant traditionally used to treat diseases in Africa. This study was undertaken to investigate the potential of the phytochemicals in S. obtusifolia as drug candidate for treatment of aflatoxin synthesis. 20 compounds through a GC-MS analysis and their 2D structures were extracted from Pubchem server. The 3D structure of polyketide synthase A, a poisonous and carcinogenic chemical substance, produced by Aspergillus flavus and Aspergillus parasiticus, which is the target protein was obtained from RCSB PDB server, and were utilized for analysis of molecular binding affinity of the drug-like compounds. Bioavailability radar was used for a rapid assessment of drug-likeness in which physicochemical properties such as: lipophilicity, size, polarity, solubility, flexibility and saturation were taken into consideration. The result showed inhibition of the target protein polyketide synthase A. The molecular interactions and in silico pharmacokinetics profiling of the best binding five compounds from the molecular docking process were assessed. The docking results showed that cis-oleic acid, methyllinolelaidate, stearic acid, methyl-11-octadecenoate, and methyl-n-octadecanoate, showed superior inhibitory potential through their respective docking scores: -9.214, -9.213, -8.688, -8.343 and -8.303 kcal/mol, in addition to good pharmacokinetics profiles compared to palmitic acid -a natural substrate which has a docking score of -8.097. In bioavailability radar, physicochemical range on each axis was depicted as a pink area in which the radar plot of the molecule has to fall entirely to be considered drug-like. This study showed that S. obtusifolia can serve as phytotherapy in treatment of health problems caused by aflatoxin.

Pages 10-18
Year 2026
Issue 1
Volume 10

Download

Posted by aiman

msm.01.2026.05.09

ABSTRACT

DISCRIMINATING CAPACITY OF SERUM Α1-ANTITRYPSIN IN NIGERIAN TB CARE

Matrix Science Medica (MSM)
Author: Olawuyi Abdullahi Olaleyea, Olaniyan Mathew Folaranmi, Ijeoma Evangeline Umeche, Abdulwaheed Adewale Ademosun, Adeosun O. Ganiyu , Ademuyiwa Isaac Adewole,Godfrey Innocent Iyare, Olatunbosun Luqman Olayinka, Busira Tijani Adesina

DOI: 10.4103/MTSM.MTSM_05_09

α1-antitrypsin (A1AT) levels in active TB is not consistent and performance in routine Nigerian care is not well defined . A cross-sectional, three-arm case–control study with N = 75 (25 Non-TB; 25 NewDx; 25 Treated TB) was conducted. Serum A1AT measured by immunoassay. We compared groups via ANOVA and Welch post-hoc with Hedges g; and estimated ROC AUCs with bootstrap 95% CIs. A1AT was highest in NewDx TB (293.7 ± 73.9 mg/dL) vs Non-TB (151.5 ± 25.9) and Treated TB (160.0 ± 22.6); ANOVA p < 0.001. Discrimination for Non-TB vs NewDx: AUC 0.928 (95% CI 0.833–1.000), threshold ~220 mg/dL, sensitivity 0.88, specificity 1.00; for Non-TB vs All-TB: AUC 0.772 (0.667–0.869), threshold ~167 mg/dL, sensitivity 0.68, specificity 0.80. In Nigerian care, A1AT provides excellent triage discrimination for newly diagnosed TB and moderate discrimination when treated cases are included. A1AT-guided referral to confirmatory testing warrants multi-site validation, quality assurance, and cost-effectiveness evaluation.

Pages 05-09
Year 2026
Issue 1
Volume 10

Download

Posted by aiman